Saarto, T., Blomqvist, C., Risteli, J., Risteli, L., Sarna, S., & Elomaa, I. (1998). Aminoterminal propeptide of type I procollagen (PINP) correlates to bone loss and predicts the efficacy of antiresorptive therapy in pre- and post-menopausal non-metastatic breast cancer patients. Nature Publishing Group|1.

Saarto, T., C. Blomqvist, J. Risteli, L. Risteli, S. Sarna, and I. Elomaa. Aminoterminal Propeptide of Type I Procollagen (PINP) Correlates to Bone Loss and Predicts the Efficacy of Antiresorptive Therapy in Pre- and Post-menopausal Non-metastatic Breast Cancer Patients. Nature Publishing Group|1, 1998.

Saarto, T., et al. Aminoterminal Propeptide of Type I Procollagen (PINP) Correlates to Bone Loss and Predicts the Efficacy of Antiresorptive Therapy in Pre- and Post-menopausal Non-metastatic Breast Cancer Patients. Nature Publishing Group|1, 1998.